Gilead Sciences Profile

71.01
0.56  0.78%
Last 1 Month(s)
71.0176.38   
Trading Day 
70.5872.0   

Gilead Sciences Summary

Gilead Sciences Inc (GILD) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 8,000 people. Gilead Sciences is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare with concentration in Pharmaceuticals And Biosciences. The company currently falls under 'Large-Cap' category with current market capitalization of 96.27 B. Gilead Sciences Inc has 1.32 B outstanding shares of which 15.82 M shares are currently shorted by private and institutional investors with about 1.65 trading days to cover. GILEAD SCIENCES currently holds about 12.27 B in cash with 18.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.31.
  

Selected Gilead Sciences Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Gilead Sciences Against Markets

Gilead Sciences Leadership

John Martin Chairman and CEO, MBA
Kathleen Watson Executive Vice President - Human Resources
More Executives

Gilead Sciences Diversification Suggestion

Use Gilead Sciences to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Gilead Sciences to be traded at 69.59 in 30 days
Gilead Sciences Inc., a researchbased biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the AsiaPacific. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameGilead Sciences Inc
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock
RegionNorth America
LocationCALIFORNIA, U.S.A
Business AddressFoster City, CA
Foreign Associates
ExchangeNASDAQ
CIK Number0000882095
ISINUS3755581036
CUSIP375558103
BenchmarkNYSE
Websitehttp://www.gilead.com
Contact Number650 574 3000
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Recommendations
Gilead Sciences Analyst Recommendations
Target PriceAdvice# of Analysts
105.0Buy13Odds
Gilead Sciences Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Gilead Sciences Analyst Advice  
Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  
Earnings
Gilead Sciences Earnings Estimates
EPSEstimate Date
Quarterly Estimate2.74November 1, 2016
Gilead Sciences Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate